Vertical Divider
eMagin Reports Yet Another Disappointing Quarter
eMagin’s Q320 earnings report had total revenues $7.3 million, a decline 7.7% Y/Y and 5.2% sequentially. The decline in product revenue was due to lower sales to medical and commercial customers related to the economic impact of COVID-19. Operating loss for the third quarter of 2020 was $1.9 billion compared to an operating loss of $0.4 million in the prior year period, reflecting lower revenue year-over-year and higher R&D expense.
Table 1: eMagin Selected Q330 Financials
eMagin’s Q320 earnings report had total revenues $7.3 million, a decline 7.7% Y/Y and 5.2% sequentially. The decline in product revenue was due to lower sales to medical and commercial customers related to the economic impact of COVID-19. Operating loss for the third quarter of 2020 was $1.9 billion compared to an operating loss of $0.4 million in the prior year period, reflecting lower revenue year-over-year and higher R&D expense.
Table 1: eMagin Selected Q330 Financials
Source: eMagin (10K)